Dr Nora Khaldi announced as new CEO of Nuritas
As seen in The Times, Dr Nora Khaldi has been announced new CEO of Nuritas.
“I am excited to have been appointed to the role of CEO at Nuritas and honored to lead the Company into this next exciting evolution of our business. This handover from previous CEO Emmet Browne is the conclusion of a transition process that began in early 2019. I thank Emmet for everything he has done over the past number of years and wish him well.
We have a lot of interesting ongoing projects and have made some great hires to build on our leadership team. We are well placed to take advantage of the opportunities that lay in front of us.
You may recall that late last year we announced the expansion of our peptide discovery efforts with the establishment of a US-based Nuritas pharma operation. This expansion enables Nuritas to serve global health needs with both preventative and therapeutic approaches. It does this by leveraging our AI platform and significant peptide discovery expertise toward novel therapeutic approaches for the treatment of conditions with significant unmet need, including fibrosis and cancer, to name just a couple.”
Dr Nora Khaldi, CEO, Founder and acting CSO